Effect of delayed graft function and ALG on the circaseptan (about 7-day) rhythm of human renal allograft rejection.
Postimplantation records of 157 kidney transplant recipients with first rejection episodes within 50 days of surgery were studied. Of these 36 had living-related and 121 cadaver donors. Recipients of cadaver donor kidneys were divided into four subgroups: with and without postoperative acute renal failure (ARF), and with and without approximately two weeks of immunosuppression by antilymphoblast globulin (ALG) added to conventional therapy. All recipients with immediate function without ALG showed evidence of periodicity in probability of occurrence of rejection that was highly significant for a 7-day period beginning at the time of surgery. The remaining groups showed less significant periodicity or no significant periodicity beginning at the time of surgery, but they did show a highly significant circaseptan rhythm of rejection episodes beginning with cessation of ALG treatment or with onset of diuresis following ARF in the absence of ALG. It is suggested that clinical manifestation of the immunologic attack of recipient upon graft has an intrinsic development period of about 7 days beginning with implantation. However, initiation of the first period may be blocked by ALG or by low renal blood flow during ARF.
D058186:Acute Kidney Injury / Q000628:therapy; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D002102:Cadaver; D002940:Circadian Rhythm; D004231:Diuresis; D006084:Graft Rejection; D006801:Humans; D007668:Kidney / Q000502:physiology; D016030:Kidney Transplantation
D000961:Antilymphocyte Serum